Abiomed, Inc. ABMD
381.02 +381.02
Day range unavailable
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Mar 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 |
|---|---|---|---|---|---|
| 1.03B | 847.52M | 840.88M | 769.43M | 593.75M | |
| 843.60M | 685.62M | 689.58M | 639.87M | 495.17M | |
| 140.72M | 229.56M | 249.22M | 224.81M | 157.14M | |
| 136.50M | 225.53M | 203.01M | 259.02M | 112.17M | |
| 2.98 | 4.94 | 4.43 | 5.61 | 2.45 |
Balance sheet
| Fiscal year | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 |
|---|---|---|---|---|---|
| 132.82M | 232.71M | 192.34M | 121.02M | 42.98M | |
| 1.67B | 1.49B | 1.22B | 1.05B | 786.38M | |
| 170.07M | 164.68M | 151.00M | 117.46M | 96.85M | |
| 1.50B | 1.33B | 1.07B | 936.89M | 689.52M |
Cash flow
| Fiscal year | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 |
|---|---|---|---|---|---|
| 285.39M | 274.58M | 314.92M | 252.20M | 192.55M | |
| -380.99M | -223.34M | -125.45M | -116.45M | -180.76M | |
| -2.20M | -8.07M | -117.72M | -55.77M | -9.14M | |
| -35.76M | -53.38M | -44.01M | -44.00M | -55.86M | |
| -99.89M | 40.37M | 71.32M | 78.05M | 3.94M |